MedTrace Logo

The Effect of Capacitive and Resistive Electrical Transfer Therapy on Hamstring Injuries

NCT07421570 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2026-08-10

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the effects of capacitive resistive electric transference (CRET), which is frequently used in clinics and sports clubs for professional soccer players with hamstring injuries. The main questions it aims to answer are:

Return to sports time Treatments sessions number Muscle oxygen saturation

The investigators will administer the treatment to a experimental group to see if CRET therapy is effective. The investigators will also administer a standard rehabilitation program to both the control and experimental groups.

Participants will:

Come for treatment and evaluations 3 times a week until participants meet the criteria for returning to sports.

Conditions

  • Hamstring Injury

Interventions

DEVICE

T-Plus; Wintecare SA, Chiasso, Switzerland

Experimental Group (Capacitive and Resistive Electrical Transfer Therapy (CRET) Therapy): In addition to the standard rehabilitation program, CRET therapy (T-Plus; Wintecare SA, Chiasso, Switzerland) will be applied at the end of each session to the experimental group. Positioning: The athlete will be placed in a prone position, with the passive electrode placed under the quadriceps muscle and the active electrode applied in the direction of the hamstring muscle fibers using classic massage maneuvers. Dosage and Duration: The treatment will last a total of 20 minutes, consisting of 10 minutes in resistive mode followed by 10 minutes in capacitive mode. Intensity: The application will start at 70% intensity. If the thermal sensation reaches a level that disturbs the athlete, the intensity will be gradually reduced by 10% to achieve the maximum tolerable thermal effect.

OTHER

Exercise

A standard hamstring rehabilitation program consisting of three phases will be implemented.

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • Irem DUZGUN · Hacettepe University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-12
Primary Completion
2026-07-13
Completion
2026-07-13

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07421570 on ClinicalTrials.gov